A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial
Background The effect of bevacizumab plus mFOLFOX6 on downsizing of liver metastases for curative [...]
